Area Development
ImClone is closing a manufacturing center in Branchburg, New Jersey, MyCentralJersey.com reports. The company, a subsidiary of pharmaceutical firm Eli Lilly, will lay off 140 workers.

"This decision was made after careful consideration of a number of internal and external factors related to Erbitux [a cancer drug]," said Janice Chavers, an Eli Lilly spokesperson. "The decision was not driven by Lilly's larger restructuring effort."

ImClone currently has 90 open positions for which employees affected by the layoffs will have priority. The closure plans are effective immediately.